Sharepoint Solutions
PRODUCTS
-
A quick overview of this industry-changing technology as well as the newer Cas9 variants that expand its use.
-
Technology solutions for life sciences that get products to market quickly and efficiently.
-
CAI’s Kneat: Data Ready provides you with best-in-class content and templates created by industry-leaders, giving you a headstart in implementing your own Kneat solution.
Kneat: Data Ready offers not only templates, but a validated out-of-the-box configuration that you can tailor to your business needs. Implement your Kneat instance in less than half the time.
-
Platform of automated, single-use systems for tangential flow filtration at multiple scales.
-
Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
WHITE PAPERS AND CASE STUDIES
-
Expert Guidance For EU Gene Therapy And Companion Diagnostic Trial Regulations
This playbook provides a concise yet comprehensive roadmap for navigating Europe’s multifaceted regulatory environment when conducting gene therapy trials involving GMOs and CDx.
-
HVLD Technology Pre-Filled Syringe Inspection
Advanced HVLD technology delivers non-invasive, deterministic inspection for pre-filled syringes. Learn how this method improves reliability and patient safety compared to traditional approaches.
-
Enabling CDMOs To Focus On Core Priorities
Explore innovative solutions for CDMO's striving to remain competitive as the biopharmaceutical market grows and evolves.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
Stopper Migration In Frozen Pre-Filled Syringes
Review a semi-automated method for dynamically assessing plunger migration under controlled variations in temperature and pressure, utilizing computer vision tools.
-
CRO Leverages Integrated Central IBC Partnership To Initiate Sites
Learn how a CRO was able to accelerate review times so COVID-19 vaccine trial sites could progress through site selection, IRB/IBC submission, approval, drug shipment, and complete site initiation visits in record time.
-
Pharma R&D Review 2024: Pleasant Weather Ahead
Gain insights from the 2024 pharma landscape, which reports a record-breaking 22,825 pipeline drugs, led by Pfizer's 32 new candidates and a strong focus on oncology and neurological treatments.
-
Hospital-Based eCOA Implementation: Real Challenges In Infectious Disease Trials
This resource outlines proven strategies to reduce delays, improve compliance, and meet regulatory standards for PRO data in infectious disease studies.
-
Response To FDA Black Box Warning
The FDA has launched an investigation into the risk of T-cell malignancies following CAR-T cell immunotherapies. Review the key points of this announcement concerning the CGT research community.
-
2025 Trends In Patient Recruitment: From Disruption To Precision
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
Strategic Pre-IND Consulting For Gene Therapy In Rare Leukemia
Learn about the collaborative efforts of an innovative biotech startup and Ergomed Consulting to overcome challenges in the pre-IND phase for a novel gene therapy targeting a rare form of leukemia.
-
Project Orbis Drug Registration 2025
Project Orbis helps streamline the review and approval of oncology medicinal products through international regulatory collaboration. Learn how this framework can accelerate your regulatory strategy.
NEWS
-
H2APEX And Copenhagen Infrastructure Partners Enter Into Strategic Partnership For Pioneering Hydrogen Project In Lubmin8/5/2025
H2APEX Group SCA announces that Copenhagen Infrastructure Partners (CIP) – one of the world’s leading investment companies in energy infrastructure investments – has acquired a majority stake of 70% in the first phase of H2APEX’s IPCEI-funded hydrogen project in Lubmin through its Energy Transition Fund (CI ETF I) as a strategic investor.
-
Coolbrook Achieves Breakthrough In Circular Materials: Large-Scale Pilot Successfully Cracks Plastic Waste Pyrolysis Oil9/15/2025
Coolbrook, a transformational technology and engineering company, has achieved a major breakthrough in circular plastics and materials by successfully cracking 100% plastic-waste-derived pyrolysis oil (py-oil) at its large-scale pilot facility using the RotoDynamic Reactor (RDR) technology.
-
Diasorin Submits The LIAISON NES Point-Of-Care Molecular Diagnostics System And 4-Plex Respiratory Panel To The FDA For 510(k) Clearance And CLIA Waiver7/2/2025
Diasorin announces the submission of a 510(k) premarket notification and CLIA waiver application to the U.S. Food and Drug Administration (FDA) for its LIAISON NES, a next-generation molecular POC testing platform.
-
Motivosity Launches Lifestyle Spending Accounts To Help Companies Offer Flexible, Hassle-Free Employee Perks5/27/2025
Motivosity, the leading people-first employee recognition and rewards platform built for today’s workforce, is proud to announce the launch of its new Lifestyle Spending Accounts (LSAs) program.
-
Groundbreaking New Partnership For Global Test & Measurement Company Axiometrix Solutions In France3/27/2025
By today, Frank Mayer, CCO of Axiometrix Solutions and representatives of French distributor Equipements Scientifiques (ES), signed an agreement about a partnership between the two companies, representing a milestone for the expansions of the sales channel in the EMEA region.